肺炎链球菌对抗菌药物耐药机制研究进展

被引:10
作者
徐敏 [1 ]
张建华 [1 ]
臧国庆 [2 ]
机构
[1] 上海交通大学附属第六人民医院儿科
[2] 上海交通大学附属第六人民医院感染科
关键词
肺炎链球菌; 耐药机制; 耐药基因;
D O I
10.16718/j.1009-7708.2008.02.009
中图分类号
R515 [细菌传染病、球菌传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:152 / 156
页数:5
相关论文
共 24 条
[1]  
Alterations in murM,a cell wallmuropeptid branching enzyme,increase high level-penicillinand cephalosporin resitance in Streptococcus pneumoniae. Smith AM,Klugman KP. Antimicrobial Agents and Chemotherapy . 2001
[2]  
Novel PCR-restriction fragment length polymorphism method for deter-minings serotypes or serogroups of Streptococcus pneumoniaeisolates. Batt SL,Charalambous BM,McHugh TD,et al. Journal of Clinical Microbiology . 2005
[3]  
The mef(E)-car-rying genetic element(mega)of Streptococcus pneumoniae:insertion sites and association with other genetic elements. Del Grosso M,Camilli R,Iannelli F,et al. Antimicrobial Agents and Chemotherapy . 2006
[4]  
Macrolide efflux inStreptococcus pneumoniae is mediated by a dual efflux pump(mel and mef)and is erythromycin inducible. Ambrose KD,Nisbet R,Stephens DS. Antimicrobial Agents and Chemotherapy . 2005
[5]  
All detectablehigh-molecular-mass penicillin-binding proteins are modifiedin a high-level beta-lactam-resistant clinical isolate of Strepto-coccus mitis. Amoroso A,Demares D,Mollerach M,et al. Antimicrobial Agents and Chemotherapy . 2001
[6]  
The CiaRH system ofStreptococcus pneumoniae prevents lysis during stress in-duced by treatment with cell wall inhibitors and by mutationsin pbp2x involved in beta-lactam resistance. Mascher T,Heintz M,Zahner D,et al. Journal of Bacteriology . 2006
[7]  
The murMN operon:a func-tional link between antibiotic resistance and antibiotic toler-ance in Streptococcus pneumoniae. Filipe SR,Severina E,Tomasz A. Proceedings of the National Academy of Sciences of the United States of America . 2002
[8]  
Site-specific mutagenesis analysis ofPBP1A from a penicillin-cephalosporin-resistant pneumococ-cal isolate. Smith AM,Klugman KP. Antimicrobial Agents and Chemotherapy . 2003
[9]  
Penicillin-binding protein1A,2B,and2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae. Nichol KA,Zhanel GG,Hoban DJ. Antimicrobial Agents and Chemotherapy . 2002
[10]  
Activities of ceftobiprole andotherβ-lactams against Streptococcus pneumoniae clinical Iso-lates from the United States with defined substitutions inpenicillin-binding proteins PBP1a,PBP2b and PBP2x. Davies TA,Shang W,Bush W. Antimicrobial Agents and Chemotherapy . 2006